Mitigating iftar-related glycemic excursions in adolescents and young adults with type 1 diabetes on MiniMed™ 780G advanced hybrid closed loop system: a randomized clinical trial for adjunctive oral vildagliptin therapy during Ramadan fasting.

Notably, during none fasting hours, despite complexity of iftar meals, a highly significant improvement of TIR was achieved with vildagliptin compared with the control group, which is well above the 5% change that was considered to be clinically significant in the recent consensus statement [ 61 ].

also in 132,142 other papers